The effects of systemic injections of dopaminergic agents on normal and weak latent inhibition of a conditioned passive avoidance reaction were studied in rats. Formation of normal latent inhibition was induced using 20 pre-exposures to a contextual conditioned stimulus prior to training. Weak latent inhibition was modeled using 10 pre-exposures. The effects of the D2/D3 receptor agonist quinpirole (1 mg/kg) and the D1 receptor agonist SKF 38393 (1 mg/kg) separately and in combination with haloperidol (0.5 mg/kg) were tested. Quinpirole induced the expression of normal latent inhibition but had no effect on weak latent inhibition. Activation of D1 receptors with SKF 38393 had no effect on the formation of latent inhibition regardless of the number of pre-exposures. Haloperidol significantly strengthened weak latent inhibition but impaired normal latent inhibition. Administration of haloperidol in combination with SKF 38393 prevented this impairment. These results suggest that while D1 receptors have no influence as an independent substrate on the formation of latent inhibition, activation of these receptors is required for the complete manifestation of D2-mediated modulation of this process.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
N. I. Dubrovina and L. V. Loskutova, Dopaminergic Mechanisms of Memory and Attention [in Russian], Siberian Branch, Russian Academy of Medical Sciences, Novosibirsk (2003).
L. V. Loskutova, “Effects of repeated pre-exposures of a conditioned stimulus on the development of amnesias of different origins,” Byul. Sib. Otd. Ros. Akad. Med. Nauk., No. 1, 13–16 (1992).
S. Ahlenius, “Clozapine: dopamine D1 receptor agonism in the prefrontal cortex as the code to decipher a Rosetta stone of antipsychotic drugs,” Pharmacol. Toxicol., 84, 193–196 (1999).
S. Barak and I. Weiner, “Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor,” Neuropsychopharmacology, 32, No. 5, 989–999 (2007).
J. M. Brooks, M. Sarter, and J. P. Bruno, “D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex,” Neuropharmacology, 53, No. 3, 455–463 (2007).
L. Chagas-Martinich, R. J. Carey, and M. P. Carrera, “7-OH-DPAT effects on latent inhibition: low dose facilitation but high dose blockade: implications for dopamine receptor involvement in attentional processes,” Pharmacol. Biochem. Behav., 86, No. 3, 441–448 (2007).
B. Di Cara, F. Panayi, A. Gobert, A. Dekeyne, D. Sicard, L. De Groote, and M. J. Millan. “Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats,” Int. J. Neuropsychopharmacol., 10, No. 3, 383–399 (2007).
J. Feldon, A. Shofel, and I. Weiner, “Latent inhibition is unaffected by direct dopamine agonists,” Pharmacol. Biochem. Behav., 38, No. 2, 309–314 (1991).
J. A. Gray, J. Feldon, J. N. P. Rawlins, D. R. Hemsley, and A. D. Smith, “The neurophysiology of schizophrenia,” Behav. Brain Sc., 14, 1–84 (1991).
J. A. Gray, P. M. Moran, G. Grigoryan, S. L. Peters, A. M. Young, and M. H. Joseph, “Latent inhibition: the nucleus accumbens connection revisited,” Behav. Brain Res., 88, No. 1, 27–34 (1997).
M. H. Joseph, S. L. Peters, P. M. Morgan, G. A. Grigoryan, A. M.Young, and J. A. Gray, “Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning,” Neurosci., 101, 921–930 (2000).
M. B. Knable and D. R. Weinberger, “Dopamine, the prefrontal cortex and schizophrenia,” J. Psychopharmacol., 11, 123–131 (1997).
F. Karoum and M. F. Egan, “Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens and striatum: a comparison of acute clozapine and haloperidol,” Brit. J. Pharmacol., 105, 703–707 (1992).
V. Kumari, P. A. Cotter, O. F. Mulligan, S. A. Checkley, N. S. Gray, D. R. Hemsley, J. C. Thornton, P. J. Corr, B. K. Toone, and J. A. Gray, “Effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteers,” J. Psychopharmacol., 13, No. 4, 398–405 (1999).
L. Lacroiz, L. M. Broersen, J. Feldon, and I. Weiner, “Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition prepulse inhibition and amphetamine induced activity,” Behav. Brain Res., 107, No. 1–2, 111–121 (2000).
R. E. Lubow, “Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia,” Schizophrenia Bull., 31, No. 1, 139–153 (2005).
S. Miyamoto, G. E. Duncan, C. E. Marx, and J. A. Lieberman, “Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs,” Mol. Psychiatry, 10, 79–104 (2005).
M. A. Pezze, J. W. Dalley, and T. W. Robbins, “Differential roles of D1 and D2 receptors in the nucleus accumbens in attentional performance on the five-choice serial reaction time task,” Neuropsychopharmacology, 32, No. 2, 273–283 (2007).
R. J. Ralph-Williams,V. Lehmann-Masten, and M. A. Geyer, “Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice,” Neuropsychopharmacology, 28, No. 1, 108–118 (2003).
C. Rascle, O. Mazas, G. Vaiva, M. Raybois, M. Goudemand, and P. Thomas, “Clinical features of latent inhibition in schizophrenia,” Schizophrenia Bull., 51, No. 2–3, 149–161 (2001).
H. Russig, A. Kovacevic, C. A. Murphy, and J. Feldon, “Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion,” Psychopharmacology (Berl.), 170, No. 3, 263–270 (2003).
J. D. Salamone, “The involvement of nucleus accumbens dopamine in appetitive and aversive motivation,” Behav. Brain Res., 61, No. 2, 117–133 (1994).
P. Sokoloff, B. Giros, M. Martres, M. Bouthenet, and J. S. Schwartz, “Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics,” Nature, 347, 146–151 (1990).
C. W. Stevenson and A. Gratton, “Role of basolateral amygdala dopamine in modulating prepulse inhibition and latent inhibition in the rat,” Psychopharmacology (Berl.), 176, No. 2, 139–145 (2004).
K. M. Trimble, R. Bell, and D. King, “Effects of the selective dopamine D(1) antagonists NNC 01-0112 and SCH 39166 on latent inhibition in the rat,” Physiol. Behav., 77, No. 1, 115–129 (2002).
I. Weiner, “The ‘two-headed’ latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment,” Psychopharmacology, 169, 257–297 (2003).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Vysshei Nervnoi Deyatel’nosti imeni I. P. Pavlova, Vol. 59, No. 2, pp. 185–191, March–April, 2009.
Rights and permissions
About this article
Cite this article
Loskutova, L.V., Kostyunina, N.V. & Dubrovina, N.I. Involvement of Different Types of Dopamine Receptors in the Formation of Latent Inhibition of a Conditioned Passive Avoidance Reaction in Rats. Neurosci Behav Physi 40, 483–487 (2010). https://doi.org/10.1007/s11055-010-9285-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-010-9285-5